Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Onc real “ value” can be realized, only by science

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Nov 02, 2022 10:02am

168 Views

Post# 35065986

RE:RE:RE:Onc real “ value” can be realized, only by science

fox7mf wrote: Lesalpes, 1) prognostication on B/O amounts are fun, and help pass the time while we wait. Nobody puts too much weight in these 'educated' guesses. 2) results are already (3 of 3) way above so -so, and judging from the excitement from those involved, will continue to be. 3) you aren't the fun police! Kidding...GLTA!!!!!!!

I have to close it like HC the dummy!

<< Previous

Bullboard Posts

Next >>

10 common investing mistakes to avoid